Semaglutide Concurrently Improves Vascular and Liver Indices in Patients With Type 2 Diabetes and Fatty Liver Disease.
Korakas E, Kountouri A, Pavlidis G, Oikonomou E, Vrentzos E, Michalopoulou E, Tsigkou V, Katogiannis K, Pliouta L, Balampanis K, Pililis S, Malandris K, Tsapas A, Siasos G, Ikonomidis I, Lambadiari V.
Korakas E, et al. Among authors: tsapas a.
J Endocr Soc. 2024 Jul 8;8(8):bvae122. doi: 10.1210/jendso/bvae122. eCollection 2024 Jul 1.
J Endocr Soc. 2024.
PMID: 38979402
Free PMC article.